To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Esophagitis, Reflux Clinical Trial

Official title:
A Randomized, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Z-215 Compared With Rabeprazole Sodium in the Treatment of Erosive Esophagitis

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of Z-215 (10 mg, 20 mg, 40 mg) , compared with Rabeprazole Sodium 10mg in patients with erosive esophagitis of Grade A to D as defined by the LA classification grading system.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02463643
Study type	Interventional
Source	Zeria Pharmaceutical
Contact
Status	Completed
Phase	Phase 2
Start date	May 2015
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00321737` - Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis	Phase 3
Completed	`NCT00255151` - Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis	Phase 3
Completed	`NCT00255164` - Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis	Phase 3
Suspended	`NCT00282555` - Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis	Phase 2
Completed	`NCT00251719` - Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis	Phase 3
Completed	`NCT00251693` - Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis	Phase 3
Not yet recruiting	`NCT05418920` - Clinical Trial of Reconstruction After Proximal Gastrectomy	N/A
Recruiting	`NCT02049723` - Assessment of GERD Knowledge Level Among Patients With it in Korea	N/A